 Antithrombin III
"Antithrombin III" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A plasma alpha 2 glycoprotein that accounts for the major antithrombin activity of normal plasma and also inhibits several other enzymes. It is a member of the serpin superfamily.
| Descriptor ID |
D000990
|
| MeSH Number(s) |
D12.644.822.750.060.500 D12.644.861.060.500 D12.776.124.790.106.125 D12.776.377.715.085.125 D12.776.645.750.060.500 D12.776.872.060.500 D23.113.025
|
| Concept/Terms |
Antithrombin III- Antithrombin III
- Serpin C1
- Heparin Cofactor I
- Cofactor I, Heparin
- Heparin Co-Factor I
- Heparin Co Factor I
AT III- AT III
- Baxter Brand of Antithrombin
- Antithrombin Baxter Brand
Thrombate III- Thrombate III
- Bayer Brand of Antithrombin
- Antithrombin Bayer Brand
Atenativ- Atenativ
- Pharmacia Brand of Antithrombin
- Antithrombin Pharmacia Brand
Kybernin- Kybernin
- Aventis Behring Brand of Antithrombin III
Antithrombin III-Alpha- Antithrombin III-Alpha
- Antithrombin III Alpha
- Antithrombin IIIAlpha
- Grifols Brand of Antithrombin
- Antithrombin Grifols Brand
|
Below are MeSH descriptors whose meaning is more general than "Antithrombin III".
Below are MeSH descriptors whose meaning is more specific than "Antithrombin III".
This graph shows the total number of publications written about "Antithrombin III" by people in UAMS Profiles by year, and whether "Antithrombin III" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2023 | 0 | 1 | 1 | | 2020 | 1 | 0 | 1 | | 2015 | 2 | 0 | 2 | | 2014 | 1 | 0 | 1 | | 2008 | 0 | 1 | 1 | | 2003 | 0 | 1 | 1 | | 1993 | 0 | 1 | 1 | | 1989 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Antithrombin III" by people in Profiles over the past ten years.
-
Quinn T, Cholette JM, Pinto MG, Schreiber H, Madden MA, Bennett E, Kolmar A, Poole A, Silva CT, Ehrlich L, Navarro OM, Faustino EVS. Antithrombin activity and central venous catheter-associated thrombosis in critically ill children at high risk of bleeding. J Thromb Haemost. 2024 Jan; 22(1):213-224.
-
Omecene NE, Kishk OA, Lardieri AB, Walker LK, Bhutta AT. Comparison of Antithrombin III Products in Pediatric Patients Receiving Extracorporeal Membrane Oxygenation. ASAIO J. 2020 Sep/Oct; 66(9):1042-1047.
-
Niebler RA, Woods KJ, Murkowski K, Ghanayem NS, Hoffman G, Mitchell ME, Punzalan RC, Scott JP, Simpson P, Tweddell JS. A Pilot Study of Antithrombin Replacement Prior to Cardiopulmonary Bypass in Neonates. Artif Organs. 2016 Jan; 40(1):80-5.
-
Miyakawa K, Joshi N, Sullivan BP, Albee R, Brandenberger C, Jaeschke H, McGill MR, Scott MA, Ganey PE, Luyendyk JP, Roth RA. Platelets and protease-activated receptor-4 contribute to acetaminophen-induced liver injury in mice. Blood. 2015 Oct 08; 126(15):1835-43.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|